Kanbi  Pharma  Teknoloji  Limite
1000025-07-9 Vadadustat

1000025-07-9 Vadadustat

Non pwodwi: Vadadustat
CAS: 1000025-07-9
MF: C14H11Cln2O4
MW: 306.7
Einecs:
MDL No.:MFCD30470233

Voye rechèch
Dekri teren

Pwopriyete

Aparans blan nan poud blan-blan
Pwen k ap fonn: 172-174 degre
Pwen bouyi: 674.6 ± 55. 0 degre
Dansite 1.461 ± 0. 06 g\/cm3
 

Aplikasyon:

Vadadustat se yon faktè ipoksi ki ka jwenn prolil idroksilaz inibitè (HIF-PHI) prensipalman itilize pou tretman anemi ren. Vadadustat amelyore absòpsyon fè ak mobilizasyon pa ogmante andojèn pwodiksyon eritropoyetin, osi byen ke downregulating hepcidin ankouraje pwodiksyon wouj nan san.

 

Sinonim:

Vadadustat

1000025-07-9

N-(5- (3- chlorophenyl) -3- hydroxypyridine -2- carbonyl) Glycine

Glycine, n-[[5- (3- chlorophenyl) -3- hydroxy -2- piridinil] carbonyl]-

2- [5- (3- chlorophenyl) {{3}

(5- (3- chlorophenyl) -3- hydroxypicolinoyl) Glycine

2- {[5- (3- chlorophenyl) -3- hydroxypyridin -2-

 

Baj popilè: 1000025-07-9 Vadadustat, Lachin 1000025-07-9 Vadadustat Konpayi fabrikasyon, Swèd

Inquiry
goTop

(0/10)

clearall